Studies to Slow or Stop Parkinson's Disease
Webinar Thursday, October 15, 12 to 1 p.m. ET
The holy grail of Parkinson’s research is a therapy that will slow or stop the disease, and this year we made great strides toward such a treatment.
“I feel like we’re in one of the peak periods in terms of innovation and the exciting science that has moved from the laboratory,” says MJFF CEO Todd Sherer, PhD, in our latest podcast.